Skip Navigation
Skip to contents

JLC : Journal of Liver Cancer

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
2 "Min Kyu Kang"
Filter
Filter
Article category
Publication year
Editorial
Sonazoid contrast-enhanced ultrasonography for the diagnosis of hepatocellular carcinoma: strengths and shortcomings
Sung Won Lee, Min Kyu Kang, Xiang Zhang
J Liver Cancer. 2023;23(2):238-240.   Published online September 20, 2023
DOI: https://doi.org/10.17998/jlc.2023.09.12
  • 2,150 Views
  • 96 Downloads
  • 1 Citation
PDF

Citations

Citations to this article as recorded by  
  • Hepatocellular carcinoma imaging: Exploring traditional techniques and emerging innovations for early intervention
    Hariharan Thirumalai Vengateswaran, Mohammad Habeeb, Huay Woon You, Kiran Balasaheb Aher, Girija Balasaheb Bhavar, Govind Sarangdhar Asane
    Medicine in Novel Technology and Devices.2024; 24: 100327.     CrossRef
Close layer
Review Article
Contrast-enhanced Ultrasonography: The Third Modality for Differentiation of Liver Mass
Min Kyu Kang, Moon Young Kim, Seong Hee Kang, Soon Koo Baik
J Liver Cancer. 2019;19(2):91-96.   Published online September 30, 2019
DOI: https://doi.org/10.17998/jlc.19.2.91
  • 5,768 Views
  • 108 Downloads
  • 2 Citations
AbstractAbstract PDF
Contrast-enhanced ultrasonography (CEUS) using microbubble ultrasonography contrast agent can show the vascular structure and unique contrast enhancement patterns of focal liver lesions, including hepatocellular carcinoma (HCC). CEUS shows three phases, similar to a vascular pattern on computer tomography (CT), and typical arterial enhancement and portal or late phase washout in HCC. CEUS can show real-time images without nephrotoxicity or radiation hazard and can be used as guidance for loco-regional treatment and estimation of treatment response of HCC. In addition, some data recently revealed the usefulness of CEUS in the early estimation of response to anti-cancer pharmacological (i.e., sorafenib) therapy in advanced HCC. Although CEUS has limitations in clinical practice and more investigation is needed for its validation, it is recommended as a main diagnostic modality in a few major clinical practice guidelines for HCC. Thus, greater understanding of CEUS is necessary to extend its application in real practice for diagnosis and management of diseases.

Citations

Citations to this article as recorded by  
  • The value of contrast-enhance ultrasound in the diagnosis of hepatic post-transplant lymphoproliferative disease: Four case reports
    Xingqi Lu, Jingtong Yu, Litao Ruan, Kazushi Numata, Dong Zhang, Feiqian Wang
    Intractable & Rare Diseases Research.2024; 13(4): 245.     CrossRef
  • Perfluorobutane-Enhanced Ultrasound for Characterization of Hepatocellular Carcinoma From Non-hepatocellular Malignancies or Benignancy: Comparison of Imaging Acquisition Methods
    Seungchul Han, Se Woo Kim, Sungeun Park, Jeong Hee Yoon, Hyo-Jin Kang, Jeongin Yoo, Ijin Joo, Jae Seok Bae, Jeong Min Lee
    Ultrasound in Medicine & Biology.2023; 49(10): 2256.     CrossRef
Close layer

JLC : Journal of Liver Cancer
TOP